AOP173 key event associated pathway predictor - online application for the prediction of benchmark dose lower bound (BMDLs) of a transcriptomic pathway involved in MWCNTs-induced lung fibrosis

Nanotoxicology. 2022 Mar;16(2):183-194. doi: 10.1080/17435390.2022.2064250. Epub 2022 Apr 22.

Abstract

Nano-QSAR model allows for prediction of the toxicity of materials that have not been experimentally tested before by linking the nano-related structural properties with the biological responses induced by nanomaterials. Prediction of adverse effects caused by substances without having to perform time- and cost-consuming experiments makes QSAR models promising tools for supporting risk assessment. However, very often, newly developed nano-QSAR models are not used in practice due to the complexity of their algorithms, the necessity to have experience in chemoinformatics, and their poor accessibility. In this perspective, the aim of this paper is to encourage developers of the QSAR models to take the effort to prepare user-friendly applications based on predictive models. This would make the developed models accessible to a wider community, and, in effect, promote their further application by regulators and decision-makers. Here, we describe a web-based application that enables to predict the transcriptomic pathway-level response perturbated in the lungs of mice exposed to multiwalled carbon nanotubes. The developed application is freely available at http://aop173-event1.nanoqsar-aop.com/apps/aop_app. It requires only two types of input information related to analyzed nanotubes (their length and diameter) to assess the doses that initiate the inflammation process that may lead to lung fibrosis.

Keywords: Nano-QSAR; multiwalled carbon nanotubes; nano-AOP; transcriptomic; web-based application.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benchmarking
  • Lung
  • Mice
  • Nanotubes, Carbon* / chemistry
  • Nanotubes, Carbon* / toxicity
  • Pulmonary Fibrosis* / chemically induced
  • Pulmonary Fibrosis* / pathology
  • Transcriptome

Substances

  • Nanotubes, Carbon